• Master cell regulator blocks all but one outcome

    A regulatory protein actively blocks the expression of non-neuronal genes in nerve cells, according to new Stanford research. The finding suggests there are many master regulators to help cell types maintain their identities.

  • Testing new insulin delivery systems for kids

    Researchers at the School of Medicine and Lucile Packard Children’s Hospital are testing easier ways for younger children with Type 1 diabetes to get the doses of insulin they need.

  • Stanford experts to discuss hot topics in medicine

    A free webinar on the Zika virus will be the first in a series of continuing medical education seminars on controversial issues in medicine, hosted by Stanford experts.

  • Ronald Levy and Howard Chang honored

    Stanford cancer researchers Ronald Levy and Howard Chang have been named Outstanding Investigators by the National Cancer Institute. They were awarded grants of up to $7 million over six years to advance their studies.

  • Drug discovery conference set for April 24

    The daylong conference at Stanford will create a platform for discussion of policy, research and venture topics with a variety of speakers.

  • Delivering flowers, encouragement to patients

    Volunteers assemble unused flowers from florists, grocery stores and flower markets into new bouquets, then hand deliver them to patients at Stanford Hospital and other Bay Area hospitals.

  • Diagnosing cancer without biopsy

    A Stanford-led team of researchers has developed tiny bubbles that bind to malignant tumors, making them visible to ultrasound imaging.

  • Grants awarded for cancer immunotherapy

    The Parker Institute for Cancer Immunotherapy at Stanford hands out its first grants to researchers who hope to translate scientific discoveries into new therapies for cancer patients.

2023 ISSUE 3

Exploring ways AI is applied to health care